Researchers evaluated the microbial characteristics driving ankylosing spondylitis pathogenesis, and they examined the effects of tumor necrosis factor inhibitor therapy on the microbiome.
The Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) have updated consensus definitions of invasive fungal diseases.
Shower aerosols may be a significant source of non-tuberculous mycobacteria exposure in homes.
Nearly one-third of patients with cystic fibrosis-related hospitalizations have aspergillosis, which is associated with worse outcomes.
Management of infection in cystic fibrosis is complex but plays a critical role in improving the survival of those with CF.
Histoplasmosis is associated with a wide spectrum of illness and a substantial burden for some patients.
Guidelines have been updated for screening and treatment for tuberculosis infection among health care personnel.
Azithromycin leads to significant drops in treatment intensification and step-up in hospital care.
CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness.
Hands can be vehicles for transmission of pneumococcus and lead to acquisition of nasopharyngeal colonization.
